• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Famed marathoner uses Abbott glucose sensor for training

April 12, 2021 By Brian Buntz

Abbott logo updatedKenyan long-distance runner Eliud Kipchoge is using a glucose sensor modeled after Abbott Laboratories’ FreeStyle Libre glucose monitor to optimize his training regimen. 

The sensor, known as the Libre Sense Glucose Sport Biosensor, is the first device intended to help athletes track blood sugar rather than people with diabetes. 

Kipchoge, who set a world record for a marathon at the 2018 Berlin Marathon, will wear the sensor at the upcoming NN Mission Marathon in the Netherlands, a qualifying race for the Tokyo Olympics. His fellow teammates on the NN Running Team will also wear the biosensor. 

Eliud Kipchoge
Eliud Kipchoge shown wearing Abbott’s Libre Sense to monitor glucose levels. Image courtesy of Abbott.

Kipchoge said in a statement that the glucose sensor has transformed how he trains. “I am learning how my glucose levels relate to my running performance and have already started to see how quickly small adjustments can make a big difference,” he explained. 

Abbott launched the product in Europe last September. 

Like other recent continuous glucose monitor (CGM) models, such as the latest FreeStyle Libre and the forthcoming Dexcom G7, the Abbott Libre Sense can collect up to 14 days of glucose data. 

The NN Running Team athletes plan to use data from the device to finetune athletes’ carbohydrate loading before races.

The technology will also enable athletes to replenish glucose levels during events. “Abbott’s biosensor enables us to build personalized nutrition plans based on glucose data in order to deliver peak athletic performance and a competitive advantage,” said Valentijn Trouw, performance director of NN Running Team and Global Sports Communications, in a statement. 

Filed Under: Diabetes Tagged With: Abbott Laboratories, Abbott Libre Sense, CGM, continuous glucose monitor, Diabetes, glucose sensor

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

About Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS